Registry collecting real-world data and samples from people with kidney cancer
Collects patient records and samples from people with kidney cancer across France.
Plain-language title generated from the registry record
Registry title: UroCCR Database: French Research Network for Kidney Cancer -UroCCR
Key facts
- Where
- Angers, Bordeaux, Cabestany, Caen, Chalon-sur-Saône, Clermont-Ferrand, Colmar, Corbeil-Essonnes, Creil, Créteil, Dijon, Fontainebleau, Hénin-Beaumont, La Roche-sur-Yon, La Tronche, Le Mans, Le Puy-en-Velay, Levallois-Perret, Libourne, Lille, Limoges, Longjumeau, Lyon, Marseille, Meaux, Metz, Mont-de-Marsan, Montauban, Montpellier, Nancy, Nantes, Nice, Nîmes, Orléans, Paris, Périgueux, Plérin, Poitiers, Quincy-sous-Sénart, Quint-Fonsegrives, Reims, Rennes, Rouen, Saint-Etienne, Saint-Herblain, Saint-Martin-d'Hères, Strasbourg, Toulouse, Tours, and Vandœuvre-lès-Nancy, FranceSee the 65 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with kidney cancer. Their care and disease data, and biological samples, are collected for a national research database.
- Age
- 18 Years and older (adults)
- Sex
- All sexes can join.
- Disease stage
- Kidney cancer; no particular stage is named.
Main reasons for not taking part
- Patients who oppose the collection of their data for the study cannot join.
Read by machine on 9 November 2026.
Where in France
- CHU AngersAngers, FranceTaking people
- CHU BordeauxBordeaux, FranceTaking people
- Clinique Tivoli-DucosBordeaux, FranceTaking people
- Polyclinique Médipôle Saint-Roch_CabestanyCabestany, FranceTaking people
- CHU CaenCaen, FranceTaking people
- Centre hospitalier Chalon sur SaôneChalon-sur-Saône, FranceNot yet recruiting
- CHU de Clermont-FerrandClermont-Ferrand, FranceTaking people
- Hôpitaux Civils de ColmarColmar, FranceNot yet recruiting
- CH Sud FrancilienCorbeil-Essonnes, FranceTaking people
- Groupe Hospitalier Public Du Sud De L OiseCreil, FranceNot yet recruiting
- CHU Henri Mondor - APHPCréteil, FranceTaking people
- CHU de Dijon et CLCC DijonDijon, FranceTaking people
- CH du Sud Seine et MarneFontainebleau, FranceTaking people
- Polyclinique d'Henin BeaumontHénin-Beaumont, FranceNot yet recruiting
- Centre Hospitalier Départemental de VendéeLa Roche-sur-Yon, FranceNot yet recruiting
- CHU GrenobleLa Tronche, FranceTaking people
- Pôle Santé SudLe Mans, FranceTaking people
- Clinique Bon Secours-ELSANLe Puy-en-Velay, FranceNot yet recruiting
- Hôpital Franco-BritanniqueLevallois-Perret, FranceNot yet recruiting
- CH LibourneLibourne, FranceTaking people
- CHRU Lille - Centre Oscar LambretLille, FranceTaking people
- Hôpital Privé La LouviereLille, FranceTaking people
- CHU LimogesLimoges, FranceTaking people
- Clinique de l'YvetteLongjumeau, FranceNot yet recruiting
- HCL LyonLyon, FranceTaking people
- APH MarseilleMarseille, FranceTaking people
- Institut Paoli-CalmetteMarseille, FranceTaking people
- Grand Hopital de l'Est FrancilienMeaux, FranceNot yet recruiting
- Centre Hospitalier d' Annecy GenevoisMetz, FranceNot yet recruiting
- CH Mont de MarsanMont-de-Marsan, FranceTaking people
- Clinique du Pont de ChaumeMontauban, FranceTaking people
- CHU de MontpellierMontpellier, FranceNot yet recruiting
- CHRU de NancyNancy, FranceTaking people
- CHU de NantesNantes, FranceTaking people
- CHU de NiceNice, FranceTaking people
- Clinique Saint-GeorgeNice, FranceTaking people
- CHU de NîmesNîmes, FranceTaking people
- CHU d'OrléansOrléans, FranceTaking people
- CH St JosephParis, FranceTaking people
- CHU Kremlin Bicêtre - APHPParis, FranceTaking people
- CHU Tenon - APHPParis, FranceTaking people
- Hopital Bichat, APHPParis, FranceTaking people
- Hôpital Cochin Port-Royal - APHPParis, FranceTaking people
- Hôpital Européen Georges Pompidou APHPParis, FranceTaking people
- Hôpital Pitié-Salpêtrière - APHPParis, FranceTaking people
- Hopital Saint LouisParis, FranceNot yet recruiting
- Institut Mutualiste MontsourisParis, FranceNot yet recruiting
- Polyclinique FranchevillePérigueux, FranceTaking people
- Hôpital Privé des Côtes d'ArmorPlérin, FranceTaking people
- CHU PoitiersPoitiers, FranceTaking people
- Hôpital privé Claude GalienQuincy-sous-Sénart, FranceTaking people
- Clinique La Croix Du SudQuint-Fonsegrives, FranceTaking people
- CHU ReimsReims, FranceTaking people
- CHU Rennes - Centre Eugène MarquisRennes, FranceTaking people
- CHU RouenRouen, FranceTaking people
- Chu St-EtienneSaint-Etienne, FranceTaking people
- Clinique Santé Atlantique de NantesSaint-Herblain, FranceTaking people
- Clinique Urologique Nantes AtlantisSaint-Herblain, FranceTaking people
- Clinique BelledonneSaint-Martin-d'Hères, FranceTaking people
- CHU StrasbourgStrasbourg, FranceTaking people
- ICANSStrasbourg, FranceTaking people
- CHU Toulouse - Centre Claudius RégaudToulouse, FranceTaking people
- Clinique PasteurToulouse, FranceTaking people
- CHRU ToursTours, FranceTaking people
- Institut de Cancérologie lorraineVandœuvre-lès-Nancy, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Bordeaux
- Trial code
- NCT03293563
- Record updated
- 25 June 2026
- Original description
Kidney cancer management has become increasingly complex with the diversification of treatment options and the integration of multidisciplinary care. To meet these challenges, the UroCCR network was established in France as a national registry and research platform dedicated to renal cancer. Funded by the French National Cancer Institute (INCa), UroCCR prospectively collects comprehensive real-world data on patient care and disease evolution, while systematically linking these records with annotated biological samples (plasma, urine, and both healthy and tumour tissues). For each case, more than one thousand variables may be recorded, covering clinical, imaging, and patient-reported information.Read full original descriptionShow less
UroCCR Database: French Research Network for Kidney Cancer (National Multidisciplinary Clinical and Biological Database on Kidney Cancer)
Kidney cancer management has become increasingly complex with the diversification of treatment options and the integration of multidisciplinary care. To meet these challenges, the UroCCR network was established in France as a national registry and research platform dedicated to renal cancer. Funded by the French National Cancer Institute (INCa), UroCCR prospectively collects comprehensive real-world data on patient care and disease evolution, while systematically linking these records with annotated biological samples (plasma, urine, and both healthy and tumour tissues). For each case, more than one thousand variables may be recorded, covering clinical, imaging, and patient-reported information.
More than a registry, UroCCR is a collaborative network of clinical and research professionals using a shared, evolving tool that supports rapid implementation of studies and fosters active knowledge generation. Unlike retrospective registries or sample-centred biobanks, UroCCR offers prospective, patient-focused inclusion and a wide scope of investigation-from translational and technological research to clinical evaluation and social sciences. It also supports multiple ancillary studies, including retrospective analyses and prospective clinical or observational trials, and operates under a structured governance system with recognised national and international labels.
By combining a rigorously structured, multicentre dataset with linkage to the French national health data system (SNDS), the platform uniquely unites detailed clinical annotation with population-wide coverage, creating a high-value environment for advancing kidney cancer research and care.
Inclusion: Adult patient with kidney cancer; Patient with no opposition to collection of its data for the study.